Dyax Corp. Announces Fourth Quarter and Full Year 2012 Financial Results
Dyax Corp. (NASDAQ: DYAX) today announced financial results for the fourth quarter and year ended December 31, 2012. Dyax will host a webcast and conference call at 5:00 p.m. (ET) today to review financial results and updates regarding its key value drivers - the KALBITOR®(ecallantide) business and angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).